MannKind | MNKD - 보통주 자본





보통주 자본 변화 날짜
Adma Biologics USD 225.36M 6.93M 2026-06
BioCryst Pharmaceuticals USD 255.26M 42.2M 2026-06
Eli Lilly USD 943.5M 3.33M 2026-03
Halozyme Therapeutics USD 113.94M 106K 2026-09
Insmed USD 218.28M 1.76M 2026-06
Karyopharm Therapeutics USD 22.54M 4.23M 2026-03
MacroGenics USD 63.65M 86K 2026-06
MannKind USD 321.63M 11.72M 2026-09
Merck USD 2.47B 1.05M 2026-06
Minerva Neurosciences USD 1000 0 2024-09
Novavax USD 162.58M 106K 2025-12
Novo Nordisk DKK 4.43B 13.25M 2026-06
Pfizer USD 5.7B 1000K 2026-09
Sanofi EUR 1.2B 0 2026-09
Xencor USD 74.33M 265K 2026-06